%define keywords for footnotes
\def\present{a}
\def\crystal{b}
\def\packing{c}
\def\jnkfig{d}
\def\alternate{e}
\def\ligdens{f}
{\small
\begin{tabular}[t]{l|l@{ (}l@{, }l@{)\qquad}l|l|l|lll}
Target     & \multicolumn{4}{c|}{Used structure}                          & \multicolumn{2}{c}{Alternate structure} & \multicolumn{3}{c}{Ligand Information}\\
           &\multicolumn{3}{c}{PDB} & DPI & Best quality & Ligand similarity > 1.4 & Count & Dyn. Range  & std(DG)\\
           &\multicolumn{3}{c}{} &  &               & & &  [$\mathrm{kcal\,mol^{-1}}$] & [$\mathrm{kcal\,mol^{-1}}$] \\ 
\hline
BACE\cite{cumming_structure_2012,wang_accurate_2015}  & 4DJW        & HT                     & 0.32          & 0.11 
    &  \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
          3TPP\tnote{\present}~ & HT & 0.28 \\
          6UWP& HT & 0.28
        \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3IN3\tnote{\present}~ & HT & 0.36 \\ 
        3INF & HT & 0.33 \\ 
        4DJV & HT & 0.31 \\ 
        3LHG & HT & 0.36 \\ 
        3INH  & HT & 0.33 
      \end{tabular} 
      & 36 & 3.9 & 0.8\\
%
% BACE(HUNT1) stuce 3ZOV one was not used in the benchmark studies.
% BACE(HUNT1) & 3ZOV        & MT                     & 0.4           & 0.2  
    % & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
    %     3TPP\tnote{\present}~ & HT & 0.28 \\
    %     6UWP& HT & 0.28 
    %   \end{tabular}
%     & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
%         4J0T & HT & 0.33 \\
%         5YGY & HT & 0.37 \\
%         4J0P & HT & 0.34 \\
%         4J0Y & HT & 0.30 \\
%         5HU1 & HT & 0.29 \\
%       \end{tabular} 
%     &   &    &    \\
% %
BACE\_HUNT\cite{hunt_spirocyclic_2013,ciordia_application_2016,keranen_acylguanidine_2017} & 4JPC        & HT                     & 0.32          & 0.12 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}}
        3TPP\tnote{\present}~ & HT & 0.28 \\ 
        6UWP& HT & 0.28
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4JP9\tnote{\present}~ & HT & 0.31 \\
        4JPE & HT & 0.35 \\
        4JOO & HT & 0.33 \\
        4RRO & HT & 0.33 
      \end{tabular}  
    & 32 & 4.9 & 1.2 \\
%
BACE\_P2\cite{malamas_design_2010,keranen_acylguanidine_2017}    & 3IN4        & HT                     & 0.59          & 0.28 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3TPP\tnote{\present}~ & HT & 0.28 \\
        6UWP& HT & 0.28
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}}
        3IN3\tnote{\present}~ & HT & 0.36 \\
        3LHG & HT & 0.36 \\
        3INF & HT & 0.33 \\
        4DJV & HT & 0.31
      \end{tabular} 
    & 12 & 0.9 & 0.3\\
%
CDK2\cite{hardcastle_substituted_2004,wang_accurate_2015}       & 1H1Q        & MT                     & 0.87          & 0.28 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3DDQ\tnote{\present}~ & HT& 0.31 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4EOR\tnote{\present}~ &	HT & 0.39 
      \end{tabular} 
    & 16 & 4.3 & 1.2 \\
%
CDK8\cite{schiemann_discovery_2016,schindler_largescale_2020}       & 5HNB        & MT                     & 0.74          & 0.22 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4CRL\tnote{\present}~ & HT & 0.42 \\
        5XS2 & HT& 0.33 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        5IDN  & HT-1.2 & 0.36
      \end{tabular} 
    & 33 & 5.7 & 1.3\\
%
EG5\cite{schiemann_discovery_2010,schindler_largescale_2020}        & 3L9H        & MT                     & 0.88          & 0.18 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3K5E\tnote{\present}~ & HT & 0.35 \\
        2X7C & HT & 0.32 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3K3B & HT-0.83 & 0.41
      \end{tabular} 
    & 28 & 3.5 & 0.9 \\
%
Galectin\cite{delaine_galectin3binding_2016,manzoni_assessing_2018}   & 5E89        & MT                     & 1.04          & 0.07 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        1KJR\tnote{\present}~ & HT & 0.30 \\
        5NF7 & HT& 0.30 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4BM8\tnote{\present, \crystal}~~~~ & MT & 0.38 \\
        5OAX & HT & 0.54\\
        5ODY\tnote{\packing, \alternate}~~~~ & MT & 0.33
      \end{tabular}	
    & 8 & 2.7 & 0.8\\ 
%
HIF2a\cite{wallace_smallmolecule_2016,schindler_largescale_2020}      & 5TBM        & HT                     & 0.35          & 0.17 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3H82\tnote{\present}~ & HT & 0.30 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        5UFB & HT & 0.36\\
        6D09 & HT & 0.35
      \end{tabular} 
    & 42 & 4.6 & 1.1 \\ 
%
Jnk1\cite{szczepankiewicz_aminopyridinebased_2006,wang_accurate_2015}       & 2GMX        & NT\tnote{\jnkfig}~                    &      & 0.77 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3ELJ\tnote{\present}~ & MT & 0.31  
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3V3V\tnote{\packing}~  & MT & 1.5  
      \end{tabular} 
    & 21 & 3.4 & 0.8\\
%
MCL1\cite{friberg_discovery_2013,wang_accurate_2015}       & 4HW3        & HT                     & 0.41          & 0.26 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3WIX\tnote{\present}~=1.2 & HT & 0.37\\
        6O6F& HT& 0.3   
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}}
        3WIX\tnote{\present}~=1.2 & HT & 0.37\\
        4WMU & HT & 0.41 \\
        4ZBI & HT & 0.45 \\
        4ZBF & HT & 0.35	
      \end{tabular} 
      & 42 & 4.2 & 1.1\\
%
P38(MAPK14) \cite{goldstein_discovery_2011,wang_accurate_2015} & 3FLY        & HT                     & 0.6           & 0.12 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3FMK\tnote{\present}~ & HT & 0.30 \\
        6SFI & HT& 0.30  
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3FLN & HT & 0.33 \\
        3FMH\tnote{\present}~ & HT & 0.43 \\
        3FMK\tnote{\present}~ & HT & 0.30 
      \end{tabular} 
    & 34 & 3.8 & 1.0\\
%
PDE2\cite{buijnsters_structurebased_2014,perez-benito_predicting_2018}       & 6EZF        & MT                     & 0.3           & 0.07 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        5TYY\tnote{\present}~ & HT & 0.30 \\
        6C7E & HT& 0.29 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        6B97 & HT-0.91 & 0.46
      \end{tabular} 
    & 21 & 3.2 & 0.9\\
%
PFKFB3\cite{boutard_discovery_2019,schindler_largescale_2020}     & 6HVI        & HT                     & 0.31          & 0.11 
    &         
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        6HVH\tnote{\present}~ & HT & 0.36 
      \end{tabular} 
    & 40 & 3.7 & 1.1\\
%
PTP1B\cite{wilson_structurebased_2007,wang_accurate_2015}      & 2QBS        & MT                     & 0.33          & 0.15 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        2HB1\tnote{\present}~ & HT & 0.32 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        2ZMM\tnote{\crystal}~ & MT & 0.33 \\
        2QBR\tnote{\present}~ & HT & 0.65 
      \end{tabular}
    & 16 & 4.3 & 1.2 \\
%
SHP2\cite{chen_allosteric_2016,schindler_largescale_2020}       & 5EHR        & MT                     & 0.32          & 0.1  
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        6MDD\tnote{\present}~ & HT & 0.35 \\
        6MD7 & HT & 0.35 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        5EHP\tnote{\alternate}~ & MT & 0.33 
      \end{tabular} 
    & 26 & 4.3 & 1.2 \\
%
SYK\cite{currie_discovery_2014,schindler_largescale_2020}        & 4PV0        & MT                     & 0.69          & 0.19 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4PX6\tnote{\present}~ & HT & 0.3  
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4FYO & HT-1.1 &  0.40
\end{tabular}	& 44 & 6.0 & 1.0\\
%
Thrombin\cite{baum_more_2009,wang_accurate_2015}   & 2ZFF        & HT                     & 0.3           & 0.06
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3QX5\tnote{\present}~ & HT & 0.28 \\
        5JZY & HT & 0.27 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}}
        3QX5\tnote{\present}~ & HT & 0.28 \\
        5JZY & HT & 0.27 
      \end{tabular}
    & 11 & 1.7 & 0.5\\
%
TNKS2\cite{buchstaller_discovery_2019}      & 4UI5        & HT                     & 0.29          & 0.08 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4PC9\tnote{\present}~ & HT & 0.27 \\
        4BU9 & HT & 0.29 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        4UVZ & HT & 0.29 \\
        4BU9\tnote{\present}~ & HT & 0.29 
    \end{tabular} 
    & 27 & 4.3 & 1.0\\
%
TYK2\cite{liang_lead_2013,liang_lead_2013a,wang_accurate_2015}       & 4GIH        & HT                     & 0.5           & 0.15 
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        3LXP\tnote{\present}~ & HT & 0.31 
      \end{tabular}
    & \begin{tabular}[t]{l@{ (}l@{, }l@{)}} 
        5WAL\tnote{\alternate}~ & MT-1.16 & 0.48 
    \end{tabular} 
    & 16 & 4.3 & 1.3\\
\hline
\end{tabular}
\begin{tablenotes}
\item [\present] structure was already available 6 month prior to publication of first benchmark study
\item [\crystal] crystal contacts
\item [\packing] packing
\item [\jnkfig] Fig. \ref{fig:jnk1_pdb_report}
\item [\alternate] alternate conformations
\item [\ligdens] ligand density: 0.79
\end{tablenotes}
}